Relief Cardiovascular

Pioneering device for diuretic resistant heart failure

Relief Cardiovascular is developing the Relief System, a pioneering closed-loop transcatheter implant for treating diuretic resistant heart failure. The device is permanently implanted and is designed to reduce renal vein pressure which relieves congestion in the heart.

CEO  Alex Cooper

Advent Contact Shahzad Malik

Advent invested in 2025.
Private Companies